InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Zentalis Pharmaceuticals, Inc.

ZNTL Clue Score26
United States Fiscal year ends December CIK 0001725160 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Walters Group
14 Aug 2026
10% owner
Buy
4,335,000
$3.50
$15.17M
Walters Group
31 Dec 2025
10% owner
Buy
6,459,973
$1.20
$7.75M
Scott Dunseth Myers
30 Apr 2025
Director
Buy
21,000
$1.40
$29.37K
Ingmar Bruns
6 Feb 2025
Chief Medical Officer
Buy
20,000
$2.28
$45.66K
Julia Marie Eastland
31 Jan 2025
CEO & President
Buy
28,500
$1.73
$49.34K
Luke Nathaniel Walker
31 Jan 2025
Director
Buy
14,200
$1.76
$24.97K
Jan Skvarka
31 Jan 2025
Director
Buy
60,000
$1.72
$103.45K
Kimberly Blackwell
13 Nov 2023
Chief Executive Officer
Buy
5,000
$10.29
$51.45K
David Michael Johnson
10 Nov 2023
Director
Buy
17,000
$9.88
$167.94K
Matrix Capital Management Company, LP
20 Jun 2023
10% owner
Buy indirect
4,760,000
$22.66
$107.86M
Showing 250 of 464 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 221
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 17
Sales at will 414
Transactions with no price 0
Shares from compensation/vesting 12,076,610
Sales filed before the plan box existed 397
History held since 8 Apr 2020